General
Preferred name
NALOXONE HYDROCHLORIDE
Synonyms
Naloxone HCl ()
Naloxone (hydrochloride) ()
Zimhi ()
Prenoxad ()
Naloxone hydrochloride anhydrous ()
Naloxoni hydrochloridum anhydrous ()
Narcanti ()
Naloxone ()
EN-15304 ()
Narcan Neonatal ()
NIH 7890 ()
Anhydrous naloxone hydrochloride ()
Evzio (autoinjector) ()
Narcan ()
Narconil ()
NSC-757109 ()
Nalone ()
Naloxone hydrochloride (autoinjector) ()
Evzio ()
Kloxxado ()
Naloxone (hydrochloride) ()
P&D ID
PD003081
CAS
357-08-4
465-65-6
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Antagonist (to narcotics)
First approval
1971
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION 5-HT release inhibitor (Tocris Bioactive Compound Library)
DESCRIPTION Broad spectrum opioid antagonist (Tocriscreen Total)
Compound Sets
11
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Total
External IDs
22
Properties
(calculated by RDKit )
Molecular Weight
363.12
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
5
Aromatic Ring Count
1
cLogP
1.72
TPSA
70.0
Fraction CSP3
0.53
Chiral centers
4.0
Largest ring
6.0
QED
0.78
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Endocrinology/Hormones
GPCR/G protein
Neuroscience
Neuronal Signaling
Target
Opioid Receptor
Opioid antagonist
Primary Target
Miscellaneous Opioids
MOA
Antagonist
Source data